A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer

Edward Giovannucci1

  • 1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1812 Longwood Avenue, Boston, MA 02115, USA. Edward.giovannucci@channing.harvard.edu

Insights

Lycopene, found in tomatoes, may reduce prostate cancer risk. Studies show high tomato intake, especially tomato sauce, is linked to lower risks of total and advanced prostate cancer.

Area of Science:

  • Oncology
  • Nutritional Science
  • Epidemiology

Background:

  • Prostate cancer is the most common cancer in American men, with limited established preventative measures.
  • Lycopene, a carotenoid found in tomato products, is being investigated for its potential role in cancer prevention.
  • Epidemiologic studies have yielded mixed results regarding the association between lycopene/tomato consumption and prostate cancer risk.

Purpose of the Study:

  • To review and synthesize existing epidemiologic evidence on the relationship between lycopene, tomato consumption, and prostate cancer risk.
  • To evaluate the consistency and strength of findings across various study designs and methodologies.

Main Methods:

  • Systematic review and meta-analysis of published epidemiologic studies (dietary and plasma-based).
  • Analysis of prospective cohort studies and case-control studies investigating tomato and lycopene intake.
  • Assessment of study quality and potential sources of heterogeneity in results.

Main Results:

  • Several studies suggest a 30-40% reduction in prostate cancer risk with high tomato or lycopene consumption.
  • A large prospective study indicated a 35% risk reduction for total prostate cancer and 50% for advanced forms with regular tomato sauce intake.
  • Inconsistencies exist, with some studies showing no significant association, potentially due to low consumption levels or measurement variability.

Conclusions:

  • While not definitive, current data suggest that increased consumption of tomatoes and tomato-based products may be a prudent strategy for potentially reducing prostate cancer risk.
  • Further research is needed to clarify the role of lycopene bioavailability and accurate dietary assessment methods in future studies.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...